Vectura delays results because of KPMG staff shortage
Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.
The maker of inhaled medicines was due to publish its results on 9 March but has put the announcement back to 18 March.
Vectura said the delay was nothing to with its financial results or outlook and that its guidance for results ahead of board expectations was unchanged.
"KPMG has advised Vectura that it has experienced unforeseen delays in completing its audit as a result of recent resourcing constraints arising from Covid-19," Vectura said. "As such, it has requested additional time to complete its audit procedures."
The FTSE 250 group said in January its operational performance was strong in 2020 and that the pandemic had not upset its product supply chain.
The company's shares rose 1.7% to 117p at 12:40 GMT.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.